Literature DB >> 15536134

Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression.

Cristina Aguilera1, Ruben Hoya-Arias, Guy Haegeman, Lluís Espinosa, Anna Bigas.   

Abstract

The NF-kappaB pathway plays a pivotal role in proliferation, differentiation, apoptosis, and immune responses in mammals. The NF-kappaB inhibitor, IkappaB, has classically been characterized for its ability to sequester NF-kappaB transcription factors in the cytoplasm. Nevertheless, a nuclear fraction of IkappaBalpha has consistently been detected and associated with repression of nuclear NF-kappaB. Now we show that IkappaBalpha physically associates with different repression elements such as nuclear corepressors and histone acetyltransferases and deacetylases (HDACs). More remarkably, chromatin immunoprecipitation experiments demonstrate that IkappaBalpha is recruited to the promoter regions of the Notch-target gene, hes1, together with HDAC1 and -5, whereas we did not detect IkappaBalpha associated with classical NF-kappaB target genes such as IL6 and RANTES. TNF-alpha treatment results in a temporary release of IkappaBalpha from the hes1 promoter that correlates with increased histone acetylation and transcriptional activation. In addition, we demonstrate that both IkappaB kinase-alpha and -beta are simultaneously recruited to the hes1 promoter in response to TNF-alpha, coinciding with a maximum of IkappaBalpha release and gene activation. Moreover, TNF-alpha-dependent histone H3 acetylation, release of IkappaBalpha from the hes1 promoter, and hes1 mRNA synthesis are affected in IKK-alpha(-/-) mouse embryonic fibroblasts. We propose that IkappaBalpha plays a previously undescribed role in regulating the recruitment of repression elements to specific promoters. Recruitment of IKKs to the nucleus in response to TNF-alpha may induce chromatin-associated IkappaBalpha release and gene activation. These findings provide additional insight in the cross-talk between NF-kappaB and other signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15536134      PMCID: PMC534509          DOI: 10.1073/pnas.0404429101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha.

Authors:  C Johnson; D Van Antwerp; T J Hope
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

2.  A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels.

Authors:  J Xie; D L Black
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

Review 3.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

4.  Inducible NF-kappaB activation is permitted by simultaneous degradation of nuclear IkappaBalpha.

Authors:  P Renard; Y Percherancier; M Kroll; D Thomas; J L Virelizier; F Arenzana-Seisdedos; F Bachelerie
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

5.  Combinatorial roles of the nuclear receptor corepressor in transcription and development.

Authors:  K Jepsen; O Hermanson; T M Onami; A S Gleiberman; V Lunyak; R J McEvilly; R Kurokawa; V Kumar; F Liu; E Seto; S M Hedrick; G Mandel; C K Glass; D W Rose; M G Rosenfeld
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

6.  A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.

Authors:  T T Huang; N Kudo; M Yoshida; S Miyamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

7.  Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor.

Authors:  S K Lee; J H Kim; Y C Lee; J Cheong; J W Lee
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

8.  The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.

Authors:  P Bailey; M Downes; P Lau; J Harris; S L Chen; Y Hamamori; V Sartorelli; G E Muscat
Journal:  Mol Endocrinol       Date:  1999-07

9.  Sharp, an inducible cofactor that integrates nuclear receptor repression and activation.

Authors:  Y Shi; M Downes; W Xie; H Y Kao; P Ordentlich; C C Tsai; M Hon; R M Evans
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

10.  Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization.

Authors:  C M Grozinger; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

View more
  56 in total

1.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

Review 2.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

3.  HIF-1α deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency.

Authors:  Jinwei Du; Yu Chen; Qiang Li; Xiangzi Han; Cindy Cheng; Zhengqi Wang; David Danielpour; Sally L Dunwoodie; Kevin D Bunting; Yu-Chung Yang
Journal:  Blood       Date:  2012-02-02       Impact factor: 22.113

4.  Expression of the Notch signaling pathway and effect on exocrine cell proliferation in adult rat pancreas.

Authors:  Ilse Rooman; Nele De Medts; Luc Baeyens; Jessy Lardon; Saskia De Breuck; Harry Heimberg; Luc Bouwens
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

Review 5.  Class II histone deacetylases: from sequence to function, regulation, and clinical implication.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1.

Authors:  Alex Robert-Moreno; Jordi Guiu; Cristina Ruiz-Herguido; M Eugenia López; Julia Inglés-Esteve; Lluis Riera; Alex Tipping; Tariq Enver; Elaine Dzierzak; Thomas Gridley; Lluis Espinosa; Anna Bigas
Journal:  EMBO J       Date:  2008-06-05       Impact factor: 11.598

Review 7.  The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.

Authors:  Yong Lin; Lang Bai; Wenjie Chen; Shanling Xu
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

Review 8.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

9.  Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance.

Authors:  Rosa A Sierra; Jimena Trillo-Tinoco; Eslam Mohamed; Lolie Yu; Bhagelu R Achyut; Ali Arbab; Jennifer W Bradford; Barbara A Osborne; Lucio Miele; Paulo C Rodriguez
Journal:  Cancer Res       Date:  2017-09-13       Impact factor: 12.701

Review 10.  Impact of notch signaling on inflammatory responses in cardiovascular disorders.

Authors:  Thibaut Quillard; Beatrice Charreau
Journal:  Int J Mol Sci       Date:  2013-03-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.